img

Global Liposomes Nanocarrier Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Liposomes Nanocarrier Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
Liposomes Nanocarrier Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Liposomes Nanocarrier Drug market is projected to reach US$ 10840 million in 2029, increasing from US$ 4851 million in 2022, with the CAGR of 12.2% during the period of 2024 to 2029. Demand from Hospital and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Liposomes Nanocarrier Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Liposomes Nanocarrier Drug key companies include Johnson & Johnson, Sun Pharmaceutical, CSPC, Kinyond, Teva, Fudan-Zhangjiang, Zydus Cadila, TTY Biopharma and Pacira, etc. Johnson & Johnson, Sun Pharmaceutical, CSPC are top 3 players and held % share in total in 2022.
Liposomes Nanocarrier Drug can be divided into Liposomes Drugs and Lipid Nanoparticle Drugs, etc. Liposomes Drugs is the mainstream product in the market, accounting for % share globally in 2022.
Liposomes Nanocarrier Drug is widely used in various fields, such as Hospital, Retail Pharmacy and Other,, etc. Hospital provides greatest supports to the Liposomes Nanocarrier Drug industry development. In 2022, global % share of Liposomes Nanocarrier Drug went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Liposomes Nanocarrier Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen
Sayre Therapeutics
Jazz
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences
Segment by Type
Liposomes Drugs
Lipid Nanoparticle Drugs

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Liposomes Nanocarrier Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Liposomes Nanocarrier Drug introduction, etc. Liposomes Nanocarrier Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Liposomes Nanocarrier Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Liposomes Nanocarrier Drug
1.1 Liposomes Nanocarrier Drug Market Overview
1.1.1 Liposomes Nanocarrier Drug Product Scope
1.1.2 Liposomes Nanocarrier Drug Market Status and Outlook
1.2 Global Liposomes Nanocarrier Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Liposomes Nanocarrier Drug Market Size by Region (2018-2029)
1.4 Global Liposomes Nanocarrier Drug Historic Market Size by Region (2018-2024)
1.5 Global Liposomes Nanocarrier Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Liposomes Nanocarrier Drug Market Size (2018-2029)
1.6.1 North America Liposomes Nanocarrier Drug Market Size (2018-2029)
1.6.2 Europe Liposomes Nanocarrier Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Liposomes Nanocarrier Drug Market Size (2018-2029)
1.6.4 Latin America Liposomes Nanocarrier Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Liposomes Nanocarrier Drug Market Size (2018-2029)
2 Liposomes Nanocarrier Drug Market by Type
2.1 Introduction
2.1.1 Liposomes Drugs
2.1.2 Lipid Nanoparticle Drugs
2.2 Global Liposomes Nanocarrier Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Liposomes Nanocarrier Drug Historic Market Size by Type (2018-2024)
2.2.2 Global Liposomes Nanocarrier Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Liposomes Nanocarrier Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Liposomes Nanocarrier Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Liposomes Nanocarrier Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Liposomes Nanocarrier Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Liposomes Nanocarrier Drug Revenue Breakdown by Type (2018-2029)
3 Liposomes Nanocarrier Drug Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Retail Pharmacy
3.1.3 Other
3.2 Global Liposomes Nanocarrier Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Liposomes Nanocarrier Drug Historic Market Size by Application (2018-2024)
3.2.2 Global Liposomes Nanocarrier Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Liposomes Nanocarrier Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Liposomes Nanocarrier Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Liposomes Nanocarrier Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Liposomes Nanocarrier Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Liposomes Nanocarrier Drug Revenue Breakdown by Application (2018-2029)
4 Liposomes Nanocarrier Drug Competition Analysis by Players
4.1 Global Liposomes Nanocarrier Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomes Nanocarrier Drug as of 2022)
4.3 Date of Key Players Enter into Liposomes Nanocarrier Drug Market
4.4 Global Top Players Liposomes Nanocarrier Drug Headquarters and Area Served
4.5 Key Players Liposomes Nanocarrier Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Liposomes Nanocarrier Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Profile
5.1.2 Johnson & Johnson Main Business
5.1.3 Johnson & Johnson Liposomes Nanocarrier Drug Products, Services and Solutions
5.1.4 Johnson & Johnson Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Johnson & Johnson Recent Developments
5.2 Sun Pharmaceutical
5.2.1 Sun Pharmaceutical Profile
5.2.2 Sun Pharmaceutical Main Business
5.2.3 Sun Pharmaceutical Liposomes Nanocarrier Drug Products, Services and Solutions
5.2.4 Sun Pharmaceutical Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.2.5 Sun Pharmaceutical Recent Developments
5.3 CSPC
5.3.1 CSPC Profile
5.3.2 CSPC Main Business
5.3.3 CSPC Liposomes Nanocarrier Drug Products, Services and Solutions
5.3.4 CSPC Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.3.5 Kinyond Recent Developments
5.4 Kinyond
5.4.1 Kinyond Profile
5.4.2 Kinyond Main Business
5.4.3 Kinyond Liposomes Nanocarrier Drug Products, Services and Solutions
5.4.4 Kinyond Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.4.5 Kinyond Recent Developments
5.5 Teva
5.5.1 Teva Profile
5.5.2 Teva Main Business
5.5.3 Teva Liposomes Nanocarrier Drug Products, Services and Solutions
5.5.4 Teva Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.5.5 Teva Recent Developments
5.6 Fudan-Zhangjiang
5.6.1 Fudan-Zhangjiang Profile
5.6.2 Fudan-Zhangjiang Main Business
5.6.3 Fudan-Zhangjiang Liposomes Nanocarrier Drug Products, Services and Solutions
5.6.4 Fudan-Zhangjiang Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.6.5 Fudan-Zhangjiang Recent Developments
5.7 Zydus Cadila
5.7.1 Zydus Cadila Profile
5.7.2 Zydus Cadila Main Business
5.7.3 Zydus Cadila Liposomes Nanocarrier Drug Products, Services and Solutions
5.7.4 Zydus Cadila Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.7.5 Zydus Cadila Recent Developments
5.8 TTY Biopharma
5.8.1 TTY Biopharma Profile
5.8.2 TTY Biopharma Main Business
5.8.3 TTY Biopharma Liposomes Nanocarrier Drug Products, Services and Solutions
5.8.4 TTY Biopharma Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.8.5 TTY Biopharma Recent Developments
5.9 Pacira
5.9.1 Pacira Profile
5.9.2 Pacira Main Business
5.9.3 Pacira Liposomes Nanocarrier Drug Products, Services and Solutions
5.9.4 Pacira Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.9.5 Pacira Recent Developments
5.10 Luye Pharma
5.10.1 Luye Pharma Profile
5.10.2 Luye Pharma Main Business
5.10.3 Luye Pharma Liposomes Nanocarrier Drug Products, Services and Solutions
5.10.4 Luye Pharma Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.10.5 Luye Pharma Recent Developments
5.11 Leadiant Biosciences
5.11.1 Leadiant Biosciences Profile
5.11.2 Leadiant Biosciences Main Business
5.11.3 Leadiant Biosciences Liposomes Nanocarrier Drug Products, Services and Solutions
5.11.4 Leadiant Biosciences Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.11.5 Leadiant Biosciences Recent Developments
5.12 Ipsen
5.12.1 Ipsen Profile
5.12.2 Ipsen Main Business
5.12.3 Ipsen Liposomes Nanocarrier Drug Products, Services and Solutions
5.12.4 Ipsen Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.12.5 Ipsen Recent Developments
5.13 Sayre Therapeutics
5.13.1 Sayre Therapeutics Profile
5.13.2 Sayre Therapeutics Main Business
5.13.3 Sayre Therapeutics Liposomes Nanocarrier Drug Products, Services and Solutions
5.13.4 Sayre Therapeutics Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.13.5 Sayre Therapeutics Recent Developments
5.14 Jazz
5.14.1 Jazz Profile
5.14.2 Jazz Main Business
5.14.3 Jazz Liposomes Nanocarrier Drug Products, Services and Solutions
5.14.4 Jazz Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.14.5 Jazz Recent Developments
5.15 Alnylam
5.15.1 Alnylam Profile
5.15.2 Alnylam Main Business
5.15.3 Alnylam Liposomes Nanocarrier Drug Products, Services and Solutions
5.15.4 Alnylam Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.15.5 Alnylam Recent Developments
5.16 Bausch Health
5.16.1 Bausch Health Profile
5.16.2 Bausch Health Main Business
5.16.3 Bausch Health Liposomes Nanocarrier Drug Products, Services and Solutions
5.16.4 Bausch Health Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.16.5 Bausch Health Recent Developments
5.17 Acrotech Biopharma
5.17.1 Acrotech Biopharma Profile
5.17.2 Acrotech Biopharma Main Business
5.17.3 Acrotech Biopharma Liposomes Nanocarrier Drug Products, Services and Solutions
5.17.4 Acrotech Biopharma Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.17.5 Acrotech Biopharma Recent Developments
5.18 Takeda
5.18.1 Takeda Profile
5.18.2 Takeda Main Business
5.18.3 Takeda Liposomes Nanocarrier Drug Products, Services and Solutions
5.18.4 Takeda Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.18.5 Takeda Recent Developments
5.19 Chiesi Farmaceutici
5.19.1 Chiesi Farmaceutici Profile
5.19.2 Chiesi Farmaceutici Main Business
5.19.3 Chiesi Farmaceutici Liposomes Nanocarrier Drug Products, Services and Solutions
5.19.4 Chiesi Farmaceutici Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.19.5 Chiesi Farmaceutici Recent Developments
5.20 Gilead Sciences
5.20.1 Gilead Sciences Profile
5.20.2 Gilead Sciences Main Business
5.20.3 Gilead Sciences Liposomes Nanocarrier Drug Products, Services and Solutions
5.20.4 Gilead Sciences Liposomes Nanocarrier Drug Revenue (US$ Million) & (2018-2024)
5.20.5 Gilead Sciences Recent Developments
6 North America
6.1 North America Liposomes Nanocarrier Drug Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Liposomes Nanocarrier Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Liposomes Nanocarrier Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Liposomes Nanocarrier Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Liposomes Nanocarrier Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Liposomes Nanocarrier Drug Market Dynamics
11.1 Liposomes Nanocarrier Drug Industry Trends
11.2 Liposomes Nanocarrier Drug Market Drivers
11.3 Liposomes Nanocarrier Drug Market Challenges
11.4 Liposomes Nanocarrier Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Liposomes Nanocarrier Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Liposomes Nanocarrier Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Liposomes Nanocarrier Drug Market Size Share by Region (2018-2024)
Table 4. Global Liposomes Nanocarrier Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Liposomes Nanocarrier Drug Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Liposomes Nanocarrier Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Liposomes Nanocarrier Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Liposomes Nanocarrier Drug Revenue Market Share by Type (2018-2024)
Table 9. Global Liposomes Nanocarrier Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Liposomes Nanocarrier Drug Revenue Market Share by Type (2024-2029)
Table 11. North America Liposomes Nanocarrier Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Liposomes Nanocarrier Drug Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Liposomes Nanocarrier Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Liposomes Nanocarrier Drug Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Liposomes Nanocarrier Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Liposomes Nanocarrier Drug Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Liposomes Nanocarrier Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Liposomes Nanocarrier Drug Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Liposomes Nanocarrier Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Liposomes Nanocarrier Drug Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Liposomes Nanocarrier Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Liposomes Nanocarrier Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Liposomes Nanocarrier Drug Revenue Market Share by Application (2018-2024)
Table 24. Global Liposomes Nanocarrier Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Liposomes Nanocarrier Drug Revenue Market Share by Application (2024-2029)
Table 26. North America Liposomes Nanocarrier Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Liposomes Nanocarrier Drug Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Liposomes Nanocarrier Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Liposomes Nanocarrier Drug Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Liposomes Nanocarrier Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Liposomes Nanocarrier Drug Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Liposomes Nanocarrier Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Liposomes Nanocarrier Drug Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Liposomes Nanocarrier Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Liposomes Nanocarrier Drug Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Liposomes Nanocarrier Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Liposomes Nanocarrier Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomes Nanocarrier Drug as of 2022)
Table 39. Date of Key Players Enter into Liposomes Nanocarrier Drug Market
Table 40. Global Liposomes Nanocarrier Drug Key Players Headquarters and Area Served
Table 41. Liposomes Nanocarrier Drug Product Solution and Service
Table 42. Global Liposomes Nanocarrier Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Johnson & Johnson Basic Information List
Table 45. Johnson & Johnson Description and Business Overview
Table 46. Johnson & Johnson Liposomes Nanocarrier Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Johnson & Johnson (2018-2024)
Table 48. Johnson & Johnson Recent Developments
Table 49. Sun Pharmaceutical Basic Information List
Table 50. Sun Pharmaceutical Description and Business Overview
Table 51. Sun Pharmaceutical Liposomes Nanocarrier Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Sun Pharmaceutical (2018-2024)
Table 53. Sun Pharmaceutical Recent Developments
Table 54. CSPC Basic Information List
Table 55. CSPC Description and Business Overview
Table 56. CSPC Liposomes Nanocarrier Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of CSPC (2018-2024)
Table 58. CSPC Recent Developments
Table 59. Kinyond Basic Information List
Table 60. Kinyond Description and Business Overview
Table 61. Kinyond Liposomes Nanocarrier Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Kinyond (2018-2024)
Table 63. Kinyond Recent Developments
Table 64. Teva Basic Information List
Table 65. Teva Description and Business Overview
Table 66. Teva Liposomes Nanocarrier Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Teva (2018-2024)
Table 68. Teva Recent Developments
Table 69. Fudan-Zhangjiang Basic Information List
Table 70. Fudan-Zhangjiang Description and Business Overview
Table 71. Fudan-Zhangjiang Liposomes Nanocarrier Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Fudan-Zhangjiang (2018-2024)
Table 73. Fudan-Zhangjiang Recent Developments
Table 74. Zydus Cadila Basic Information List
Table 75. Zydus Cadila Description and Business Overview
Table 76. Zydus Cadila Liposomes Nanocarrier Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Zydus Cadila (2018-2024)
Table 78. Zydus Cadila Recent Developments
Table 79. TTY Biopharma Basic Information List
Table 80. TTY Biopharma Description and Business Overview
Table 81. TTY Biopharma Liposomes Nanocarrier Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of TTY Biopharma (2018-2024)
Table 83. TTY Biopharma Recent Developments
Table 84. Pacira Basic Information List
Table 85. Pacira Description and Business Overview
Table 86. Pacira Liposomes Nanocarrier Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Pacira (2018-2024)
Table 88. Pacira Recent Developments
Table 89. Luye Pharma Basic Information List
Table 90. Luye Pharma Description and Business Overview
Table 91. Luye Pharma Liposomes Nanocarrier Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Luye Pharma (2018-2024)
Table 93. Luye Pharma Recent Developments
Table 94. Leadiant Biosciences Basic Information List
Table 95. Leadiant Biosciences Description and Business Overview
Table 96. Leadiant Biosciences Liposomes Nanocarrier Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Leadiant Biosciences (2018-2024)
Table 98. Leadiant Biosciences Recent Developments
Table 99. Ipsen Basic Information List
Table 100. Ipsen Description and Business Overview
Table 101. Ipsen Liposomes Nanocarrier Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Ipsen (2018-2024)
Table 103. Ipsen Recent Developments
Table 104. Sayre Therapeutics Basic Information List
Table 105. Sayre Therapeutics Description and Business Overview
Table 106. Sayre Therapeutics Liposomes Nanocarrier Drug Products, Services and Solutions
Table 107. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Sayre Therapeutics (2018-2024)
Table 108. Sayre Therapeutics Recent Developments
Table 109. Jazz Basic Information List
Table 110. Jazz Description and Business Overview
Table 111. Jazz Liposomes Nanocarrier Drug Products, Services and Solutions
Table 112. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Jazz (2018-2024)
Table 113. Jazz Recent Developments
Table 114. Alnylam Basic Information List
Table 115. Alnylam Description and Business Overview
Table 116. Alnylam Liposomes Nanocarrier Drug Products, Services and Solutions
Table 117. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Alnylam (2018-2024)
Table 118. Alnylam Recent Developments
Table 119. Bausch Health Basic Information List
Table 120. Bausch Health Description and Business Overview
Table 121. Bausch Health Liposomes Nanocarrier Drug Products, Services and Solutions
Table 122. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Bausch Health (2018-2024)
Table 123. Bausch Health Recent Developments
Table 124. Acrotech Biopharma Basic Information List
Table 125. Acrotech Biopharma Description and Business Overview
Table 126. Acrotech Biopharma Liposomes Nanocarrier Drug Products, Services and Solutions
Table 127. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Acrotech Biopharma (2018-2024)
Table 128. Acrotech Biopharma Recent Developments
Table 129. Takeda Basic Information List
Table 130. Takeda Description and Business Overview
Table 131. Takeda Liposomes Nanocarrier Drug Products, Services and Solutions
Table 132. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Takeda (2018-2024)
Table 133. Takeda Recent Developments
Table 134. Chiesi Farmaceutici Basic Information List
Table 135. Chiesi Farmaceutici Description and Business Overview
Table 136. Chiesi Farmaceutici Liposomes Nanocarrier Drug Products, Services and Solutions
Table 137. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Chiesi Farmaceutici (2018-2024)
Table 138. Chiesi Farmaceutici Recent Developments
Table 139. Gilead Sciences Basic Information List
Table 140. Gilead Sciences Description and Business Overview
Table 141. Gilead Sciences Liposomes Nanocarrier Drug Products, Services and Solutions
Table 142. Revenue (US$ Million) in Liposomes Nanocarrier Drug Business of Gilead Sciences (2018-2024)
Table 143. Gilead Sciences Recent Developments
Table 144. North America Liposomes Nanocarrier Drug Market Size by Country (2018-2024) & (US$ Million)
Table 145. North America Liposomes Nanocarrier Drug Market Size by Country (2024-2029) & (US$ Million)
Table 146. Europe Liposomes Nanocarrier Drug Market Size by Country (2018-2024) & (US$ Million)
Table 147. Europe Liposomes Nanocarrier Drug Market Size by Country (2024-2029) & (US$ Million)
Table 148. Asia-Pacific Liposomes Nanocarrier Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 149. Asia-Pacific Liposomes Nanocarrier Drug Market Size by Region (2018-2024) & (US$ Million)
Table 150. Asia-Pacific Liposomes Nanocarrier Drug Market Size by Region (2024-2029) & (US$ Million)
Table 151. Asia-Pacific Liposomes Nanocarrier Drug Market Share by Region (2018-2024)
Table 152. Asia-Pacific Liposomes Nanocarrier Drug Market Share by Region (2024-2029)
Table 153. Latin America Liposomes Nanocarrier Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 154. Latin America Liposomes Nanocarrier Drug Market Size by Country (2018-2024) & (US$ Million)
Table 155. Latin America Liposomes Nanocarrier Drug Market Size by Country (2024-2029) & (US$ Million)
Table 156. Middle East & Africa Liposomes Nanocarrier Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 157. Middle East & Africa Liposomes Nanocarrier Drug Market Size by Country (2018-2024) & (US$ Million)
Table 158. Middle East & Africa Liposomes Nanocarrier Drug Market Size by Country (2024-2029) & (US$ Million)
Table 159. Liposomes Nanocarrier Drug Market Trends
Table 160. Liposomes Nanocarrier Drug Market Drivers
Table 161. Liposomes Nanocarrier Drug Market Challenges
Table 162. Liposomes Nanocarrier Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liposomes Nanocarrier Drug Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Liposomes Nanocarrier Drug Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Liposomes Nanocarrier Drug Market Share by Regions: 2022 VS 2029
Figure 4. Global Liposomes Nanocarrier Drug Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Liposomes Drugs
Figure 11. Global Liposomes Drugs Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Lipid Nanoparticle Drugs
Figure 13. Global Lipid Nanoparticle Drugs Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Liposomes Nanocarrier Drug Market Size Share by Type: 2022 & 2029
Figure 15. North America Liposomes Nanocarrier Drug Revenue Market Share by Type (2018-2029)
Figure 16. Europe Liposomes Nanocarrier Drug Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Liposomes Nanocarrier Drug Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Liposomes Nanocarrier Drug Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Liposomes Nanocarrier Drug Revenue Market Share by Type (2018-2029)
Figure 20. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Retail Pharmacy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Global Liposomes Nanocarrier Drug Market Size Share by Application: 2022 & 2029
Figure 24. North America Liposomes Nanocarrier Drug Revenue Market Share by Application (2018-2029)
Figure 25. Europe Liposomes Nanocarrier Drug Revenue Market Share by Application (2018-2029)
Figure 26. Asia-Pacific Liposomes Nanocarrier Drug Revenue Market Share by Application (2018-2029)
Figure 27. Latin America Liposomes Nanocarrier Drug Revenue Market Share by Application (2018-2029)
Figure 28. Middle East and Africa Liposomes Nanocarrier Drug Revenue Market Share by Application (2018-2029)
Figure 29. Liposomes Nanocarrier Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Liposomes Nanocarrier Drug Market Share in 2022
Figure 31. North America Liposomes Nanocarrier Drug Market Share by Country (2018-2029)
Figure 32. United States Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 33. Canada Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 34. Germany Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 35. France Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 36. U.K. Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 37. Italy Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 38. Russia Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 39. Nordic Countries Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 40. Asia-Pacific Liposomes Nanocarrier Drug Market Share by Region (2018-2029)
Figure 41. China Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 42. Japan Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 43. South Korea Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 45. India Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 46. Australia Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 47. Latin America Liposomes Nanocarrier Drug Market Share by Country (2018-2029)
Figure 48. Mexico Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 49. Brazil Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Liposomes Nanocarrier Drug Market Share by Country (2018-2029)
Figure 51. Turkey Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 53. UAE Liposomes Nanocarrier Drug Market Size (2018-2029) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries